Developing a new culture platform to investigate the role of vascularisation on pancreatic progenitor maturation
Understanding metabolic factors determining COVID-19 disease progression for personalised interventions
Finding prognostic biomarkers for COVID-19 disease progression will suggest pharmaceutical and nutritional intervention strategies
Generating true capillaries with endothelial cells and supporting pericytes
Developing models to study why cancer patients are at risk to develop thrombosis
In METABOCHIP, analytical technologies and blood vessel-on-a-chip models will be developed to realise personalised medicine.